SCHEMBL20239403

SCHEMBL20239403

O=C(O)c1cnc(O)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15200818 0.76 CES1 (0.51)
SCHEMBL19556315 0.74
SCHEMBL1838907 0.74
SCHEMBL8303534 0.74
SCHEMBL7977655 0.74
SCHEMBL28869966 0.74 NLRP3 (0.39)
SCHEMBL16822656 0.74 KDM4E (0.42)
SCHEMBL5211138 0.71 CES1 (0.47)
SCHEMBL567221 0.70 CES1 (0.39)
SCHEMBL1912536 0.70 PIK3CG (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055062-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC 2026-02-26 US disclosed
US-12492171-B2 Heterocyclic inhibitors of MCT4 Vettore, LLC (US) 2025-12-09 US disclosed
EP-4442318-A2 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC (US) 2024-10-09 EP disclosed
CN-110114351-B Heterocyclic inhibitors of MCT4 维托尔股份有限公司 2022-09-20 CN disclosed
US-20220251047-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC 2022-08-11 US disclosed
US-11292767-B2 Heterocyclic inhibitors of MCT4 Vettore, LLC (US) 2022-04-05 US disclosed
EP-3551625-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC (US) 2019-10-16 EP disclosed
CN-110114351-A The heterocycle inhibitor of MCT4 维托尔股份有限公司 2019-08-09 CN disclosed
US-20190112275-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC 2019-04-18 US disclosed
WO-2018111904-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC (US) 2018-06-21 WO disclosed
US-20180162822-A1 HETEROCYCLIC INHIBITORS OF MCT4 Vettore, LLC 2018-06-14 US disclosed